Cargando…

Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection

Although the epidemic caused by SARS-CoV-2 callings for international attention to develop new effective therapeutics, no specific protocol is yet available, leaving patients to rely on general and supportive therapies. A range of respiratory diseases, including pulmonary fibrosis, have been associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carota, Giuseppe, Ronsisvalle, Simone, Panarello, Federica, Tibullo, Daniele, Nicolosi, Anna, Li Volti, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198259/ https://www.ncbi.nlm.nih.gov/pubmed/34070628 http://dx.doi.org/10.3390/jcm10112306

Ejemplares similares

Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells
por: Spampinato, Mariarita, et al.
Publicado: (2022)

Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models
por: Carota, Giuseppe, et al.
Publicado: (2022)

Antimicrobial, Antioxidant, and Cytotoxic Activities of Juglans regia L. Pellicle Extract
por: D’Angeli, Floriana, et al.
Publicado: (2021)

Commentary: The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation
por: Li Volti, Giovanni, et al.
Publicado: (2017)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Biomarkers of Oxidative Stress for Neonatal Lung Disease
por: Ferrante, Giuliana, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Propofol and α2-Agonists Attenuate Microglia Activation and Restore Mitochondrial Function in an In Vitro Model of Microglia Hypoxia/Reoxygenation
por: Longhitano, Lucia, et al.
Publicado: (2022)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Mangifera indica L. Leaf Extract Induces Adiponectin and Regulates Adipogenesis
por: Sferrazzo, Giuseppe, et al.
Publicado: (2019)

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent
Publicado: (1984)

The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation
por: Potor, László, et al.
Publicado: (2020)

Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide Reductase
por: Gaur, Kavita, et al.
Publicado: (2021)

The synthesis and properties of mitochondrial targeted iron chelators
por: Cilibrizzi, Agostino, et al.
Publicado: (2022)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
por: Camiolo, Giuseppina, et al.
Publicado: (2019)

The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators That Inhibit Their Activity
por: Park, Kyung Chan, et al.
Publicado: (2020)

Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death
por: Raffaele, Marco, et al.
Publicado: (2019)

Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells
por: Castracani, Carlo Castruccio, et al.
Publicado: (2020)

Heme Oxygenase-1 in Central Nervous System Malignancies
por: Sferrazzo, Giuseppe, et al.
Publicado: (2020)

The non-canonical functions of the heme oxygenases
por: Vanella, Luca, et al.
Publicado: (2016)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia
por: Reisi, Nahid, et al.
Publicado: (2022)

The Role of Inflammation and Inflammasome in Myeloproliferative Disease
por: Longhitano, Lucia, et al.
Publicado: (2020)

Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance
por: D’Aprile, Simona, et al.
Publicado: (2023)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
por: Amano, Shogo, et al.
Publicado: (2020)

Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib
por: Camiolo, Giuseppina, et al.
Publicado: (2020)

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
por: Asperti, Michela, et al.
Publicado: (2019)

The natural iron chelators' ferulic acid and caffeic acid rescue mice's brains from side effects of iron overload
por: AAlikhani, Mahdi, et al.
Publicado: (2022)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nnl0457qsv07ld4dt2buunnnv8